It induces antiproliferative effects, anti-inflammatory effects, G2/M phase arrest, and cell apoptosis via mitochondrial pathways by targeting cytokines and aurora kinase A (AURKA) in CRC cells (Ma et al., 2016; Liu et al., 2020e). The gene discussed is AURKA; the disease is colorectal carcinoma.